Publications by authors named "Dylan C Dean"

Claim this Profile
D
Discoidin Domain Receptor Tyrosine Kinase 1 (DDR1) Is a Novel Therapeutic Target in Liposarcoma: A Tissue Microarray Study.
Dylan C Dean, Wenlong Feng, Robert L Walker, Pichaya Thanindratarn, H Thomas Temple

Clin Orthop Relat Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of CDK7-dependent transcriptional addiction is a potential therapeutic target in synovial sarcoma.
Xiaoyang Li, Dylan C Dean, Jin Yuan, Thomas H Temple, Jonathan C Trent

Biomed Pharmacother· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and Characterization of a Novel Dedifferentiated Chondrosarcoma Cell Line DDCS2.
Xiaoyang Li, Dylan C Dean, Al Ferreira, Scott D Nelson, Francis J Hornicek

Cancer Control· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SMARCB1 expression is a novel diagnostic and prognostic biomarker for osteosarcoma.
Tao Guo, Ran Wei, Dylan C Dean, Francis J Hornicek, Zhenfeng Duan

Biosci Rep· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-LAK cell-originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcoma.
Pichaya Thanindratarn, Ran Wei, Dylan C Dean, Arun Singh, Noah Federman

Mol Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclin-dependent kinase 7 (CDK7) is an emerging prognostic biomarker and therapeutic target in osteosarcoma.
Hangzhan Ma, Dylan C Dean, Ran Wei, Francis J Hornicek, Zhenfeng Duan

Ther Adv Musculoskelet Dis· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclin-dependent kinase 12 (CDK12) in chordoma: prognostic and therapeutic value.
Pichaya Thanindratarn, Dylan C Dean, Wenlong Feng, Ran Wei, Scott D Nelson

Eur Spine J· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATR and p-ATR are emerging prognostic biomarkers and DNA damage response targets in ovarian cancer.
Wenlong Feng, Dylan C Dean, Francis J Hornicek, Jinglu Wang, Yanyan Jia

Ther Adv Med Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Significance of Cyclin E1 Expression in Patients With Chordoma: A Clinicopathological and Immunohistochemical Study.
Ran Wei, Dylan C Dean, Pichaya Thanindratarn, Francis J Hornicek, Wei Guo

Front Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-LAK cell-originated protein kinase (TOPK) is a Novel Prognostic and Therapeutic Target in Chordoma.
Pichaya Thanindratarn, Dylan C Dean, Scott D Nelson, Francis J Hornicek, Zhenfeng Duan

Cell Prolif· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclin E1 is a prognostic biomarker and potential therapeutic target in osteosarcoma.
Ran Wei, Pichaya Thanindratarn, Dylan C Dean, Francis J Hornicek, Wei Guo

J Orthop Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of ATR-Chk1 signaling blocks DNA double-strand-break repair and induces cytoplasmic vacuolization in metastatic osteosarcoma.
Xiaoyang Li, Dylan C Dean, Gregory M Cote, Lee Zou, Francis J Hornicek

Ther Adv Med Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer testis antigens in sarcoma: Expression, function and immunotherapeutic application.
Ran Wei, Dylan C Dean, Pichaya Thanindratarn, Francis J Hornicek, Wei Guo

Cancer Lett· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myc is a prognostic biomarker and potential therapeutic target in osteosarcoma.
Wenlong Feng, Dylan C Dean, Francis J Hornicek, Dimitrios Spentzos, Robert M Hoffman

Ther Adv Med Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment and Characterization of a Recurrent Osteosarcoma Cell Line: OSA 1777.
Pichaya Thanindratarn, Xiaoyang Li, Dylan C Dean, Scott D Nelson, Francis J Hornicek

J Orthop Res· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging next-generation sequencing-based discoveries for targeted osteosarcoma therapy.
Jie Zhao, Dylan C Dean, Francis J Hornicek, Xiuchun Yu, Zhenfeng Duan

Cancer Lett· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric antigen receptor T (CAR-T) cell immunotherapy for sarcomas: From mechanisms to potential clinical applications.
Pichaya Thanindratarn, Dylan C Dean, Scott D Nelson, Francis J Hornicek, Zhenfeng Duan

Cancer Treat Rev· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aberrant CDK9 expression within chordoma tissues and the therapeutic potential of a selective CDK9 inhibitor LDC000067.
Shen Shen, Dylan C Dean, Zujiang Yu, Francis Hornicek, Quancheng Kan

J Cancer· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of cyclin-dependent kinases (CDKs) in hepatocellular carcinoma: Therapeutic potential of targeting the CDK signaling pathway.
Shen Shen, Dylan C Dean, Zujiang Yu, Zhenfeng Duan

Hepatol Res· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exosomes promote pre-metastatic niche formation in ovarian cancer.
Wenlong Feng, Dylan C Dean, Francis J Hornicek, Huirong Shi, Zhenfeng Duan

Mol Cancer· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in ovarian cancer.
Jinglu Wang, Dylan C Dean, Francis J Hornicek, Huirong Shi, Zhenfeng Duan

FASEB J· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in immune checkpoint inhibitors for bone sarcoma therapy.
Pichaya Thanindratarn, Dylan C Dean, Scott D Nelson, Francis J Hornicek, Zhenfeng Duan

J Bone Oncol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA sequencing (RNA-Seq) and its application in ovarian cancer.
Jinglu Wang, Dylan C Dean, Francis J Hornicek, Huirong Shi, Zhenfeng Duan

Gynecol Oncol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From genomics to metabolomics: emerging metastatic biomarkers in osteosarcoma.
Dylan C Dean, Shen Shen, Francis J Hornicek, Zhenfeng Duan

Cancer Metastasis Rev· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis